Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
92 hedge funds and large institutions have $429M invested in Aratana Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 13 closing their positions.
913% more call options, than puts
Call options by funds: $304K | Put options by funds: $30K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 24
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
1% less funds holding
Funds holding: 93 → 92 (-1)
5% less capital invested
Capital invested by funds: $452M → $429M (-$22.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$5.4M |
| 2 |
Jennison Associates
New York
|
+$4.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.33M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.33M |
| 5 |
SCM
Sio Capital Management
New York
|
+$3.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.7M |
| 2 |
Lazard Asset Management
New York
|
-$5.74M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$3.66M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.17M |
| 5 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$1.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PSC
101
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$79K | -4,934 | Closed |
|
102
Simplex Trading
Chicago,
Illinois
| – | -$30.5K | -2,111 | Closed |
|
|
TRCT
103
Tower Research Capital (TRC)
New York
| – | -$20K | -1,246 | Closed |
|
|
BJ
104
BlackRock Japan
Tokyo,
Japan
| – | -$5K | -321 | Closed |
|
PETX Hedge Fund Activity: Q2 2015 in Review
92 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q2 2015, worth a combined $429M — down 5% from $452M a quarter earlier.
Fund positioning in PETX was balanced in Q2 2015: 13 funds opened new positions, 13 closed out, 36 added to existing stakes and 24 trimmed.
The largest buyer was Franklin Resources, adding an estimated $5.4M. The largest seller was Wellington Management Group, cutting an estimated $12.7M.
- 92 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q2 2015, down from 93 in Q1 2015.
- Funds reported $429M of Aratana Therapeutics, Inc. stock for Q2 2015, down 5% quarter-over-quarter.
- 13 funds opened new Aratana Therapeutics, Inc. positions in Q2 2015 and 13 closed out, a net change of 0 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q2 2015 was Franklin Resources, an estimated $5.4M added.
- The largest Aratana Therapeutics, Inc. seller in Q2 2015 was Wellington Management Group, an estimated $12.7M sold.
Based on aggregated 13F filings for Q2 2015.